VMX 2021: Session library
Interested in licensing this content?
Request .mp4 files of the session videos from the Academy's licensing team.Contact us for licensing inquiries
Searching for a particular topic or speaker?
To search this page for a particular topic or speaker, press and hold “CTRL + F" and then type the session name, subject, or last name you’re looking for in the search box.
Click on the links in the bulleted lists below to view individual presentations.
Climate change and dermatology
Climate change is an existential threat which is impacting the health or our patients. The science of climate change is indisputable. What is becoming markedly more evident are the health impacts of climate change. Diseases occurring in different regions and seasons. Extreme weather events with cutaneous complications. Warming weather and altered atmospheric conditions leading to increased skin cancer. Wildfires triggering flares of inflammatory skin diseases. Questions about the environmental impacts of sunscreens and new laws limiting specific ingredients' use. This session will provide learners with the updates they need to navigate this topic in their personal and professional lives.
Controversies in acne and rosacea
The management of moderate to severe acne is changing due to the need to limit the use of oral antibiotics. Alternate effective medications and tactics to successfully clear patients will be explored and evidence related to patient selection, dosing, side effects, laboratory monitoring and expected outcomes will be addressed. The new rosacea classification has weaknesses which affect the successful outcome of therapy. Controversies regarding issues in these two common conditions will be discussed.
What's new on photoprotection in 2021?
Effect of sunscreen on skin cancer development, and latest information on the environmental and health effects of UV filters will be presented. Data on percutaneous absorption of UV filters, and regulations by the FDA will be discussed. Photobiologic effects of visible light (VL), and means of VL photoprotection will be covered. Practical advice for patients and the public, including advice for people of color, will be presented.
The Pregnant Pause: How to Evaluate and Treat your Pregnant Patients
Dermatologists face multiple challenges when evaluating and treating the pregnant patient. Treatment of acne and psoriasis is difficult; risks to the fetus limit the number of evidence-based studies concerning drug therapy. Concerning melanocytic lesions, do nevi change during pregnancy, and if melanoma is diagnosed, is there a poor prognosis? Infections and infestation may present a risk for mother and fetus, and treatment options may be limited. Several dermatoses are specific for pregnancy; early recognition and management may be important to prevent adverse effects on the fetus.
Managing skin disease in the cancer patient
Dermatology practices increasingly care for patients with a history of or active cancer diagnoses. Managing skin disease in these patients can be multi-faceted and require thoughtful consideration of their skin disease in relation to cancer diagnosis and treatment. On-demand sessions will include the Use of biologics in the cancer patient; Paraneoplastic disease-diagnosis and management; Chemotherapy-induced alopecia; Checkpoint-inhibitor induced toxicities; Targeted inhibitor induced toxicities. The live session will include a panel discussion of challenging cases with ARS.
Innovate for Impact: Solving Clinical Problems through Creativity and Collaboration in Dermatology
This interactive forum will cultivate creativity and collaboration among learners. The forum features an overview of the innovation process through a series of dynamic didactic talks on how to identify clinical problems and unmet needs, how to brainstorm and prototype potential solutions, how to identify stakeholders, how to to collaborate with researchers and how to pitch solutions for further development and commercialization. The didactic talks will be punctuated with small, interactive, breakout sessions where learners can practice innovation in real-time and apply it to a clinical problem that is personally meaningful to them.
Caring for the Cancer Patient: Challenging Cases From Inpatient and Outpatient Oncodermatology Consultative Services
Dermatologic issues are one of the most common complications in patients undergoing cancer therapy. Knowledge of mucocutaneous toxicities to chemotherapy, immunotherapy, and radiation, neoplasms in cancer patients (particularly cutaneous metastases), paraneoplastic syndromes, complications of stem cell transplant, and infectious diseases of the immunosuppressed is critical in distinguishing the numerous dermatologic conditions that can arise in a patient undergoing cancer treatment. This session will cover these key topics in the field of Oncodermatology through illustrative and challenging cases seen at different academic cancer centers to enhance the knowledge of dermatologists, residents, and other practitioners caring for cancer patients.
Where do We Stand? The Pathogenesis and Treatment of Melasma
Melasma is a global disorder of major cosmetic significance. It negatively impacts the quality of life of patients. The pathogenesis of melasma is indeed complex. Multiple recent studies document the interplay of genetics, inflammation, oxidative stress, abnormal vascular responses, and sensitivity to hormones in the pathogenesis of this disorder. Recent data also suggest that it is a phenotype of photodamage. While there are no cures, multiple new therapies offer significant improvement. This forum will review the most recent global advances in the pathogenesis and treatment of melasma. Therapies to be reviewed include photoprotection including visible light, topical and oral agents, chemical peels, microneedling, lasers, and light sources.
What’s that? Syndrome Update
Using case examples, this session will review key clinical points and updates relevant to genetic skin disorders in a dermatology clinic.
How can the Appropriate Use Criteria in Dermatopathology be utilized by the practicing dermatologist?
Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making. The American Society of Dermatopathology with input from the American Academy of Dermatology and the College of American Pathologists developed AUC for 12 tests used in dermatopathology. The recommendations of appropriateness will be reviewed with an emphasis of clinical scenarios that affect the practicing dermatologist.
Translating Evidence into Practice, Current Acne Guidelines and Beyond
The most recent Acne Guidelines were published in 2016. The goal of this forum is to examine existing guidelines, reviewing what is pertinent, but also educating and updating the practitioner on issues not addressed in the previous guidelines. This will serve as a spring board for the development of new guidelines. Controversies on oral antibiotics, isotretinoin, contraceptive and hormonal therapy will be discussed as well as ideas such as lifestyle intervention, diet, and light and laser interventions.
Putting Technology to Work for You and Your Patients: Augmented Intelligence and its Role in Enhancing the Practice of Dermatology
The emerging area of Artificial Intelligence (AI) and Augmented Intelligence (AuI) is undergoing rapid development and advancement and has already begun to impact the practice of medicine and dermatologic care. We believe in the central role of clinicians and patients in the development of these data-driven tools and systems to enhance human intelligence and capabilities. While this technology holds the potential to enhance access to high-quality, patient-centered, dermatologist-led care, it can be daunting. This session is directed at clinicians who seek to further understand the current state and future potential of AI/AuI in their care of patients.
Controversies in melanoma diagnosis
The increased scrutiny has resulted in ever-increasing detection of early melanomas while the melanoma mortality has stayed flat, the implication of which is overdiagnosis of thin indolent melanomas with no impact on thick lethal melanomas. Faculty members will provide critical analyses of the current knowledge and issues surrounding the epidemiology, precursors, and diagnostic methods of melanoma. A patient-centered approach to the detection of melanoma that decreases the number needed to treat while minimizing under- and overdiagnosis of melanoma is highlighted. The session is geared toward all levels of trainees and practicing clinicians.
Techniques for Flap Success
Speakers will highlight anatomical regional areas and decision-making for flap reconstruction including flap design and execution. Attendees will have the opportunity to explore case-based surgical scenarios through high-quality video presentations in the OnDemand virtual format. Common flap repairs in each anatomic area will be presented as well as advanced techniques for experienced surgeons. Please join us for a live Q&A session to interact with speakers and other attendees for an in-depth discussion of the cases and questions.
Vasculitis and the Dermatologist
This session will review a systematic and evidence-based approach to evaluation, diagnosis, and management of patients presenting with vasculitis involving the skin. Attendees will be able to explain why we see what we see clinically in vasculitis, direct proper evaluation for systemic disease using an algorithmic approach, and institute therapies appropriate to disease severity. Special attention will be paid to care coordination with other specialties in internal medicine. Cutting edge research and new data relevant to skin vasculitis will be reviewed. The session director is board-certified in dermatology and internal medicine and runs a vasculitis specialty clinic and vasculitis-focused clinical trials.
The Elusive CTCL: An Interactive Case-based CPC for Diagnosis and Management
The goal of the session is to highlight "elusive" and clinically overlapping presentations of CTCL and to engage the audience in discussions around how to effectively work up, diagnose and treat varying subtypes of CTCL.
Let there be Light: Aesthetic Considerations in Ethnic Skin Using Lasers and Devices
The session aims to present updated, evidence-based practices and clinical pearls using lasers, energy-based devices and non-invasive procedures to manage benign dermatoses affecting patients with pigmented skin. Dermatoses include pigmentary skin conditions such as melasma and benign pigmented epidermal and dermal skin lesions, as well as common conditions such as acne scarring, keloids, postinflammatory hyperpigmentation and striae. Modalities expected for discussion may include picosecond domain lasers, microneedling, radiofrequency devices, chemical peels, and fractionated lasers. Topics to be presented will include assessment approaches, supporting literature of modalities discussed, clinical pearls and experiences, and discussion of adverse effects and management options.
Are You Smarter Than a Pediatric Dermatologist?
This high-yield session will draw from pediatric dermatology cases seen at children's hospitals. Using a case-based format and interactive questions, audience members can test their knowledge while learning new information in a fun and lighthearted manner. Cases that stumped the speakers will be emphasized. Trainees, general dermatologists, and pediatric dermatologists will all benefit from hearing the most fascinating cases from the speakers' case files.
Women’s Health Therapeutic Hotline
This therapeutics symposium highlights cutting edge issues in women’s health in dermatology. We will review new therapies available for alopecia in women and discuss optimal use of hormonal therapy for acne, including modification of the microbiome to achieve optimal results. We will discuss pruritus and erythema of the vulva and dermatologic complications of breast cancer. We will review the impact of COVID-19 on women’s health in dermatology this past year and provide answers to commonly asked questions regarding the HPV and shingles vaccines. This course is packed with clinical pearls for the practicing dermatologist.
Dietary Triggers and Modification of Common Dermatologic Conditions - An Evidence Based Approach
The role of food allergies and elimination diets will be discussed in atopic dermatitis and contact dermatitis. The link between food, metabolic syndrome and systemic inflammation in psoriasis will be reviewed. Dietary contributors to follicular occlusion and inflammation will be highlighted, incorporating the tie between insulin and mTOR pathways for acne and hidradenitis suppurativa, and the TRPV and TRAP1 receptors for rosacea. Dietary inducers and protectants of skin cancers will be reviewed. Evidence-based discussion of strategic dietary interventions will be provided, focusing on proper incorporation of current treatment paradigm for each skin conditions.
Hand and Foot Psoriasis, Dermatitis and Other Inflammatory Dermatoses
Common inflammatory dermatoses such as psoriasis, atopic dermatitis and contact dermatitis often involve hands and feet. The morphology of many of these dermatoses is different on palms and soles, making the diagnosis more challenging. In addition, inflammatory conditions involving palms and soles often do not respond as well to topical and systemic treatments. This session will review the different clinical presentations of common hand and feet dermatoses and the role of patch testing. The focus will be on the management of hand and foot psoriasis, dermatitis and palmoplantar pustulosis. Recent data on the efficacy of biological agents and oral systemic agents and will be reviewed and discussed.
Documentation and Coding: Getting Paid and Passing Audits 2021
Dermatologists often feel overwhelmed with constantly changing coding and documentation requirements as well as burdensome insurer and regulatory mandates. Insurers place hurdles to appropriate reimbursement for services and are reviewing medical records with increasing frequency. Worse yet, a dermatologist may be faced with a serious audit or recoupment demand. This session will provide dermatologists with an update of the latest coding and documentation guidelines; examine those practice and coding areas most at risk for review or audit; and outline a plan for responding to insurer medical audits.
Volunteers Abroad, Beginner Forum
Through a series of lectures and panel discussions, the audience will be introduced to the various ways global health volunteering can be accomplished starting during residency through mid to late career. We will discuss the impact COVD-19 has had on global health education and volunteer programs. Finally, we will discuss common ethical issues that arise with global health work and how to effectively prepare for them.
Acute and Chronic Pain Management in Dermatology
This forum will provide practical tips for maximizing your patients' comfort and their in-clinic experience. Both procedural and medical interventions will be reviewed within multimodal algorithms that incorporates the most recent research of the perception of pain. Participants with recognize the role of dermatologists in multidisciplinary clinical coordination and our role in resolving the ongoing opioid epidemic.
Fractional Laser and Light-based Technologies
This session is appropriate for experienced and potential users of fractional laser and light technologies. Specific treatment protocols will be outlined and tips to optimize clinical outcomes will be shared. The expert faculty will use evidence-based approaches to examine the strengths and weaknesses of current fractional technology. A review of fractionated laser skin resurfacing and rejuvenation in varying skin tones and conditions as well as a discussion of future technologic applications will provide the attendee with the latest advancements in the fields.
Integrative Dermatology: What is the Evidence?
This session explores different traditions and their approaches to dermatologic problems. From botanicals, ayurvedic approaches, herbs, and mind-body therapies, there is growing interest in these complementary therapies. Importantly, there also exists a body of evidence, and we will carefully review the extant literature.
Nutraceuticals and Cosmeceuticals
This session will investigate the latest science surrounding topicals and orals for enhancing appearance. Nutritional supplements for the skin, hair, and nails will be assessed. Topical skin care agents will be evaluated for a broad population, including skin of color. A discussion of the available data will be undertaken to assess the value of cosmeceuticals and nutraceuticals in clinical practice.
Scars: What have we learned and where are we going?
This course is intended for dermatologists with a strong foundation in scar revision treatments. Experts across the board will share the benefits and downfalls of past scar treatments and give intel on new and emerging technologies. Dive into the prospects of using energy-based devices to treat various cases of scars and stretchmarks. Understand the mechanics of different treatment options and how to optimize your services to meet your patient’s needs.
Complex Medical Dermatology
The skin is frequently reflective of internal disease. This session will update the attendees with new aspects of such diseases and prepare them for developing effective, efficient plans for evaluation of such patients. In addition, attendees will be provided with a therapeutic scheme for cost-effective management. Off-label uses of medications will occur, but we will use the best level of evidence available for the basis of the therapeutic discussions.
What's New in Skin of Color
Dermatologic diseases in skin of color is a topic of increasing relevance and importance in dermatology and in all of healthcare. This session will highlight clinical data, cases scenarios, and therapeutic updates in order to allow the attendee to better diagnose, manage and treat skin of color conditions. In addition, a discussion about healthcare disparities and the role dermatologists can play in reducing these will be incorporated.
JAK Inhibitors: The Next Frontier in Dermatology
Janus kinase (JAK) inhibitors are a relatively new class of medicine and hold tremendous promise for the treatment of a broad range of dermatologic diseases. The use of JAK inhibitors across common diseases, with significant unmet medical need, will be presented, including the results of clinical trials and case series. Safety will be discussed. The audience for this session will be dermatologists who care for adult and pediatric patients with alopecia areata, atopic dermatitis, dermatomyositis, granuloma annulare and sarcoidosis, lichen planus, morphea, pruritus, psoriasis, and vitiligo.
What's New in the Dermatology Journals
Editors of our key journals will discuss advances in medical, surgical and pediatric dermatology.
This session provides an up-to-date overview about new discoveries and therapies for atopic dermatitis. Moderated by Dr Amy Paller, topics are: Epidemiology of Atopic Dermatitis (Dr. Aaron Drucker); Multimorbidity of Atopic Dermatitis (Dr. Jonathan Silverberg); The Epidermal Barrier and its Role (Dr. Lisa Beck); The Immune System and Relevance to Targeted Therapeutics (Dr. Emma Guttman-Yassky); The Microbiome and Atopic Dermatitis (Richard Gallo, MD, PhD) ; Topical Therapy: What’s New (Dr. Lawrence Eichenfield); Systemic therapy for Adults- What’s here/ What’s coming?: (Dr. Eric Simpson); Systemics for Pediatric Patients – Are we there? (Dr. Amy Paller)
LGBTQ/SGM Health in Dermatology: Updates & Pearls in a Changing Landscape
This session aims to better enable dermatologists to provide medically appropriate, culturally sensitive, and culturally humble care to LGBTQ/SGM persons. Covering basic and advanced knowledge domains in LGBTQ/SGM healthcare, topics include skin cancer in sexual minority populations; dermatologic management of gender diverse individuals with a focus on acne, hair removal considerations, minimally invasive procedures, and the role of contraception and how to manage contraception as part of dermatology therapeutics in the gender diverse patient; and state and federal policy framework for contextualizing the impact of discrimination and its intersection with access to affirming care and health outcomes.
Acne and Rosacea Symposium
We will review the state of the art in our current understanding of the pathogenesis of acne and rosacea and compare the added benefit of new treatment options, including pipeline drugs.
This is a comprehensive overview of the latest information related to psoriasis and its therapy. Data will be presented that update our understanding of psoriasis pathophysiology and the novel small molecule and biologic agents being brought to approval for the treatment of psoriasis. Also, speakers will present new data related to currently approved therapies, with a special focus on the use of the correct therapy based on patient demographics and comorbidities, and the treatment of nail psoriasis. A review of the updated psoriasis treatment guidelines from the AAD-NPF will be covered. Finally, there will be an evidence-based review of the treatment of psoriasis during the COVID-19 pandemic.
What's New in Dermatology
In this session we will cover new surgical and cosmetic techniques, and we will review new treatments for skin diseases including psoriasis, atopic dermatitis, vitiligo, alopecia areata, hidradenitis suppurativa, acne, rosacea, warts, molluscum, and many others. We will also review new diagostic techniques to differentiate benign nevi from malignant melanoma and low risk from high risk melanomas.
Complex Medical Dermatology: Advances in evaluation and management
In this session, topics of interest to dermatologists will be presented where there have been significant advances or updates. In particular, the evaluation and treatment of hidradenitis suppuritiva is advancing. There are new treatments and guidelines for chronic urticaria that are changing treatment paradigms. Recognizing neutrophilic and granulomatous dermatoses, and the work-up and treatment is continuing to progress. There are new insights and treatments for cutaneous lupus erythematosus and dermatomyositis. In an era when there are many more biologic and immunosuppressive therapies, it is important to review recommendations on vaccination in adult patients on systemic therapy. Lastly, new sources of allergens require that dermatologists need to be kept up-to-date.
Big Rashes in Little Patients
Rashes with inflammatory and infectious etiologies often have different clinical appearances, time courses, and associated features in infants and children than in adults. This session provides an update on new and under-recognized cutaneous presentations of pediatric infections, reactive eruptions, and inflammatory dermatoses. Case-based scenarios will be utilized to provide clinical pearls, highlight the differential diagnosis, and illustrate strategies for evaluation and management. Topics will range from common but oftentimes frustrating inflammatory conditions such as psoriasis and atopic dermatitis to recent developments in infectious rashes, severe drug eruptions, and cutaneous manifestations of inflammatory bowel disease.
Vascular Anomalies Symposium: Discovery Streamlines Classification, Explains Natural History, and Offers New Hope for Treatment
This session will provide updates on this rapidly advancing field including a unique patient perspective from a mom and child affected by PHACE syndrome.
Hidradenitis Supparativa/Acne Inversa (HS/AI): Current Medical and Surgical Management
This session will review hidradenitis suppurativa (HS) epidemiology and comorbidities, and current concepts of pathogenesis. An evidence-based approach for the use of medical therapies for HS, including topical agents, antibiotics, non-antibiotic systemics and biologics, will be discussed. An evidence-based approach for the use of surgical therapies for HS, including office-based procedures, laser therapy and large surgical procedures, will be reviewed. An approach to HS pain management and the patient perspective of living with HS will also be presented.
This session will review many of the principles and hot topics in contact dermatitis. We will discuss new and upcoming allergens as well as allergens in common personal care products. It will also discuss the use of patch testing in the assessment and management of patients with atopic dermatitis as well as the nuances of occupational contact dermatitis and the use of patch testing with metal devices in addition to other challenges in the field of contact dermatitis.
Innovative technological and procedural advancements in managing alopecia
Minimally invasive scalp and hair disease technologies are rapidly advancing. This includes but is not limited to artificial intelligence based monitoring, platelet rich plasma, hair transplantation, photobiomodulation, hair transplantation and scalp hydradermabrasion. Review of evidence based data focused on these technologies is necessary for the general dermatologist.
What's New and True in Energy Based Devices
What's New and What's True in Energy Based Devices will explore evaluation of new devices as well as innovative uses of energy based devices in Skin. Speakers with both clinical and research experience will share their expertise on topics including treatment of cutaneous vascular lesions, scars, melasma, tattoos, photoaging and cellulite. The most current approaches will be discussed.
Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
Trichoscopy: An update
Trichoscopy (hair and scalp dermoscopy) evolved into a significant diagnostic tool in dermatology. The key subjects which will be covered include the role of trichoscopy in differential diagnosis of common causes of hair loss (e.g. alopecia areata, tinea capitis, androgenetic alopecia, lichen planopilaris, dissecting cellulitis), rare genetic hair shaft abnormalities (e.g. monilethrix, pili torti, thichorrhexis invaginata) and inflammatory scalp diseases (e.g. psoriasis, seborrheic dermatitis, infections). Trichoscopy features of hair loss associated with systemic disorders will be discussed.
Surgery Techniques: Basics to Advanced
This session will cover basic and advanced techniques to improve patient outcomes during cutaneous surgery. Topics are diverse and meant to address a wide range of surgical practice methods. Talks include " A three dimensional approach to the linear closure ", "The Snug-tip stitch -an innovative dog-ear repair", "5 innovative surgical techniques that can change your surgical practice and outcomes", "Pre-, Intra-, and Post-op Surgical Pearls", "Techniques to effectively manage surgical complications", “Anticipating and avoiding complications from linear closures on the face”, "Simple Ways to Improve Suboptimal Surgical Outcomes", and "Pearls for Flap Success."
Micrographic Dermatologic Surgery (MDS) Subspecialty Certification Exam Prep Course
Speakers will compose board style questions on the subject areas focusing on the high yield concepts. Questions will be answered by audience using ARS. Detailed explanations of each question will be reviewed by the faculty. We will have a live Q&A.
The symposium will address those 'hot topics' established by registrant consensus, a true reflection of member concerns and interests. The somewhat unstructured session will be a 'potpourri' of medical/surgical topics, including some with social and economic import. Expert speakers will provide 'state of the art' material, highlighting recent trends and developments and accenting emerging and innovative therapies. Presentations will be derm relevant, clinically germane, and directly applicable to patient care.
In this session we will hear from experts in COVID-19 dermatology. This symposium will serve as an overview of key topics in COVID-19, ranging from COVID skin manifestations, COVID-19 and skin of color, COVID-19 vaccines, COVID-19 and biologics, and affects of COVID on dermatology training and practice.
Access to Dermatologic Learning Collaborative
To promote knowledge sharing and an open dialogue, the format is short, “TED-like” talks that will each focus on the various innovative ways to increase access. After each 5-10 minute presentation there will be a 5-minute Q&A and discussion.
The Quality Improvement and Innovation Symposium: Better Outcomes Through QI
The session will begin with a Podcast-like format interview with Dr. Joseph Kvedar, leading teledermatology expert and Professor of Dermatology at Harvard Medical School. Next, explore rapid-fire real-life practice improvement activities underway by the 2021 “AAD Excellence in Patient Care” resident award winners. Explore QI initiatives including a skin of color workshop to improve diagnostic accuracy, a melanoma survivorship plan, guided in-home photography for telehealth visits, post-visit patient informational videos on commonly prescribed therapies, improving follow-up for no-show appointments and reducing sample tracking errors. Wrap up with project updates from the 2020 AAD Excellence in Patient Care award winners.
Neurocutaneous dysesthesias can be a challenge to diagnose and treat. We look to the literature for an evidence-based three part talk on some difficult diseases in this field: 1) what's new in neurocutaneous dysesthesias, 2) vulvodynia pearls, and 3) an update in anogenital pruritus.
Practical Practice Enhancements: Applying Evidence-Based Practice Management Strategies into Clinical Care
The practice model of the twenty first century dermatology practice is rapidly evolving. This session will highlight approaches to evidence-based practice management strategies and their implementation for enhancing patient care. Innovations and impacts of medical scribes and EHR platforms will be highlighted, alongside their impact on dermatology practices. Clinical care redesign strategies that improve patient throughput, decrease missed appointments, and optimize triage quality will be reviewed. Practical implementation of quality improvement efforts will be highlighted. All practicing dermatologists are welcome and encouraged to attend.
Lessons on Teledermatology From COVID-19 and Planning the Future
This session will review the implementation of teledermatology during the COVID-19 pandemic. First, we will discuss the changes made by the Centers for Medicaid and Medicare Services in response to the unique circumstances of maintaining care. Then, we will review and unpack survey data from the American Academy of Dermatology’s Teledermatology Task Force. We will compare goals for improving access to care with real experience, pearls and pitfalls. Finally, we will consider and discuss the implications of this teledermatology implementation experiment and consider what precedents have been set, any successes and concerns, and what the future may hold.
Skin Conditions in Asian Patients that You Do Not Want to Miss
Asian Americans currently represent the fastest growing minority group in the United States. As dermatologists, we should be mindful of providing care that is both culturally and ethnically sensitive. This focus session is targeted for general dermatologists who seek competency in treating this special patient population. During this session, we will 1) review the unique biological characteristics of Asian skin and 2) discuss how to diagnose and manage various skin conditions more prevalent in Asian patient.
Danger and Defense in the Age of Biologics
Modern dermatological practice involves an ever increasing array of therapeutic options of immunosuppressive and biological agents for our patients. Many patients live with or are at risk of acquiring chronic infectious diseases such as HIV, TB or Hepatitis. This session will address knowledge gaps in the management of these drugs in such patients. The session will also review the impact of Covid-19 on patients taking immunosuppressive or biological therapy.
Having the Difficult Conversation: Addressing Sexual Disorders with your Patient
There are several taboo subjects that are difficult for patients and dermatologists to talk about. Women are taught to be familiar with how their breasts normally look, but studies show that up to 60% of women can not identify the difference between a vulva and a vagina. We will have open dialog to destigmatize sex, vulvas, intimate partner violence, and child abuse.
How to read, review, and write a scientific article
This session is designed as a crash course in critical appraisal of the scientific literature--coupled with key tips for reviewing articles and pearls for maximizing the chances of getting your research published. The underlying skillset for reading, reviewing, and writing great scientific articles is the same--an appreciation of asking appropriate, focused clinical questions and an understanding of the fundamentals of epidemiology and biostatistics--and this session will serve as a brief introduction to these skills. This interactive session is aimed at a broad audience, though early career, resident, and international dermatologists may find it most useful.
Off-label use of biologics and new medications
During the session, off-label use of biologic and other specialty drugs will be reviewed. The aim is to help the practioner optimize the delivery of appropriate treatments for patients. Medications to be discussed include TNF-alpha inhibitors, anti-IL17 antibodies, anti-IL23 biologics, dupilumab, apremilast, and JAK inhibitors.
Managing Advanced Non-Melanoma Skin Cancer - Choosing the Right Pathway for the Right Patient
This session is intended to provide the attendee with an overview of the expanding systemic, non-surgical options for advanced non-melanoma skin cancer, for which there is no standardized management approach. While surgery is a viable option for many patients, it also may carry the risk of cosmetic and functional incapacity. Available treatments, both systemic and topical will be discussed with a focus on the data and an eye toward future developments. Attendees should be more comfortable discussing options with their patients and colleagues for the management of advanced nonmelanoma skin cancer.
High Yield Melanoma Dermoscopy Tips for the General Dermatologist
Geared toward the general dermatologist, this session will focus on the high yield dermoscopic features of melanoma to help clinicians hone their skills in diagnosing amelanotic, hypomelanotic, facial, acral, and other challenging melanomas.
Onychomycosis Nuts and Bolts
This session is a fast-paced comprehensive review of diagnosis and management of onychomycosis in 2021. Topics covered include epidemiology, diagnosis, and treatment in both adults and children. FDA approved oral and topical treatments will be discussed in detail, as well as, emerging therapies such as devices. New this year, adverse events of treatments will be discussed. Faculty include nail experts from around the world.
The Skin & Gut Axis: Cutaneous Manifestations of Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD) can present with cutaneous co-morbidities that are categorized as specific, reactive, associated, or treatment-induced. In this session, we will provide an overview of how to identify, categorize, and diagnose these cutaneous co-morbidities and address evidence-based treatment options. The session will end with a discussion regarding the importance of an interdisciplinary approach to managing IBD patients.
Pearls for Surveillance and Management of High Risk Skin Cancer Patients
This session is intended to provide attendees with incredibly high yield pearls on the surveillance and management of high risk skin cancers, especially in immunosuppressed patients such as organ transplant recipients. The pearls will be highlighted with specific case presentations as well.
Management of Difficult Wounds
Venous hypertension, peripheral arterial disease, and diabetes are the most common causes of lower extremity ulcers in the United States. Dermatologists are often involved in the work-up of difficult to heal chronic wounds to rule out more rare causes of lower extremity ulcers. Vascular and diabetic wounds can be very challenging to heal and their clinical presentation can sometimes mimic rare forms of leg ulcer disease that dermatologists are more comfortable diagnosing and treating. By the end of the session, the audience will be able to more appropriately recognize and diagnose difficult to heal lower extremity chronic ulcers.
Researchers can submit abstracts describing their most recent unpublished results. After a competitive review, the top scoring studies will be invited to discuss their findings in a brief oral presentation during one of the themed sessions. This year, there will be three Forums (clinical/pediatric dermatology, surgery/procedural dermatology and basic science/dermatopathology) and a new Clinical Trials Symposium. Together, these sessions will highlight the latest ground-breaking observations in all aspects of dermatological research.
April Armstrong, MD, MPH: Efficacy and Safety of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, Compared With Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 Study
Andrew Blauvelt, MD, MBA: Abrocitinib Induction, Randomized Withdrawal and Response Recapture With Rescue Therapy in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the JADE REGIMEN Phase 3 Trial
Emma Guttman-Yassky, MD, PhD: Etrasimod, a novel, oral, selective sphingosine 1-phosphate receptor modulator, improves patient and clinician reported outcomes in adults with moderate-to-severe atopic dermatitis in a randomized, double-blind, placebo-controlled phase 2 study (ADVISE)
Dedee F. Murrell, MD: Treatment With Rilzabrutinib Results in Rapid and Significant Decrease in Steroid Use and Improved Quality of Life in Patients With Chronic Relapsing Pemphigus: BELIEVE Phase II Study
Kristian Reich, MD, PhD: Bimekizumab efficacy and safety versus secukinumab in patients with moderate to severe plaque psoriasis: Results from a multicenter, randomized, double-blinded, active comparator-controlled phase 3b trial (BE RADIANT)
Kristian Reich, MD, PhD: Secukinumab dosing every two weeks vs every four weeks demonstrates superior efficacy in adult patients with plaque psoriasis weighing 90 kg or more, and benefits PASI 90 non-responder patients who up-titrate at Week 16
Jordan Taylor Said, BA: Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study